Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.11 USD | -5.18% | +0.65% | +53.96% |
May. 10 | Leerink Partners Starts Aquestive Therapeutics With Outperform Rating, $8 Price Target | MT |
May. 08 | Transcript : Aquestive Therapeutics, Inc., Q1 2024 Earnings Call, May 08, 2024 |
Business Summary
Number of employees: 135
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Pharmaceutical
100.0
%
| 48 | 100.0 % | 51 | 100.0 % | +6.09% |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
73.4
%
| 40 | 83.7 % | 37 | 73.4 % | -7.06% |
Ex-United States
26.6
%
| 8 | 16.3 % | 13 | 26.6 % | +73.72% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Daniel Barber
CEO | Chief Executive Officer | 48 | 07-06-30 |
A. Toth
DFI | Director of Finance/CFO | 65 | 20-12-30 |
Stephen Wargacki
CTO | Chief Tech/Sci/R&D Officer | 46 | 14-12-31 |
Cassie Jung
COO | Chief Operating Officer | 45 | 03-12-31 |
Lori Braender
CMP | Compliance Officer | 68 | 18-09-09 |
Peter Boyd
CTO | Chief Tech/Sci/R&D Officer | 58 | 13-07-31 |
Carl Kraus
CTO | Chief Tech/Sci/R&D Officer | - | 23-06-25 |
A. Schobel
CTO | Chief Tech/Sci/R&D Officer | 68 | 05-11-30 |
Joseph Crusco
PRN | Corporate Officer/Principal | - | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Timothy Morris
BRD | Director/Board Member | 61 | 22-08-09 |
Santo Costa
BRD | Director/Board Member | 78 | 15-11-30 |
Gregory Brown
CHM | Chairman | 70 | 07-02-28 |
A. Schobel
CTO | Chief Tech/Sci/R&D Officer | 68 | 05-11-30 |
John Cochran
BRD | Director/Board Member | 58 | 03-12-31 |
Marco Taglietti
BRD | Director/Board Member | 64 | 21-02-09 |
Daniel Barber
CEO | Chief Executive Officer | 48 | 07-06-30 |
Julie Krop
BRD | Director/Board Member | 57 | 21-02-09 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 91,038,532 | 86,537,069 ( 95.06 %) | 0 | 95.06 % |
Company contact information
Sector
Sales per region
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+53.96% | 283M | |
+32.09% | 693B | |
+29.39% | 584B | |
-1.34% | 372B | |
+20.34% | 332B | |
+7.39% | 294B | |
+14.25% | 239B | |
-3.03% | 211B | |
+10.02% | 210B | |
+8.49% | 168B |
- Stock Market
- Equities
- AQST Stock
- Company Aquestive Therapeutics, Inc.